The safety profile in these surgical patients was favorable, with no significant differences in adverse events between ipamorelin and placebo groups
So, what does this mean for patients and providers
Key Findings from a Large-Scale Study A large real-world study using the TriNetX Analytics Network (20102022) analyzed outcomes in 5,291 PV patients treated with GLP-1 RAs compared with 79,027 untreated patients
10.2337/diacare.29.02.06.dc05-2043 22 DolanR
GLP-1RAs provide different mechanistic effects including anti-oxidative, anti-inflammatory, and anti-atherosclerotic properties [4, 9, 11, 14, 17]
Mounjaro, Wegovy, and Zepbound single-dose auto-injectors commonly have a built-in needle